A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease
- Resource Type
- Editorial
- Source
- In
Parkinsonism and Related Disorders March 2023 108 - Subject
- Language
- ISSN
- 1353-8020